Home › High Blood Pressure › NCT07204756

HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* 18 years or older
* Discharged after delivery at University of Minnesota Medical Center
* Enrolled into the HOPE-BP Program

Exclusion Criteria:

* Ongoing antihypertensive medication use at 2 weeks (time of randomization)
* Have a medical comorbidity that would not be clinically appropriate to randomize
* Patients opted out of clinical research

About the study

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

What is being tested

• 2-Week Home Monitoring (diagnostic test)
• 6-Week Home Monitoring (diagnostic test)

Sponsor: University of Minnesota · Participants: 400 · Started: Jan 7, 2026

Contact the study team

• Erin Linden · Phone: 612-625-2273

Official record on ClinicalTrials.gov — NCT07204756

Locations in the U.S.

Conditions

• High Blood Pressure
• Toxemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.